Join Michelle Martin on her tour of markets! Hosted by Michelle Martin with Ryan Huang, this episode dives into Johnson & Johnson's $14 billion acquisition of Intra-Cellular Therapies, Eli Lilly’s and GSK’s billion-dollar deals, and Bill Ackman’s plans for a modern-day Berkshire Hathaway with Howard Hughes Holdings.

Explore Nvidia’s challenges under new US AI chip restrictions, Moderna’s sales forecast cut, and Blue Origin’s postponed rocket launch.

Discover Singapore market updates and the curious case of Dunkin’ running out of donuts.